Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease (Q78108906)
Jump to navigation
Jump to search
scientific article published on 01 January 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease |
scientific article published on 01 January 1999 |
Statements
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease (English)
G P Murphy
B A Tjoa
S J Simmons
J Jarisch
V A Bowes
H Ragde
M Rogers
A Elgamal
G M Kenny
O E Cobb
R C Ireton
M J Troychak
M L Salgaller
A L Boynton
1 January 1999